Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
1 other identifier
observational
1,000
1 country
1
Brief Summary
Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
December 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2032
November 4, 2025
November 1, 2025
11.6 years
December 12, 2023
November 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment outcomes in patients undergoing endoscopic treatment of pancreatic fluid collections.
Treatment outcomes in patients undergoing endoscopic treatment of pancreatic fluid collections.
3 years
Secondary Outcomes (15)
Treatment success
6 months
Number and type of interventions performed
6 months
Need for surgical intervention
6 months
Technical success of endoscopic interventions in pancreatic fluid collections.
6 months
Inflammatory response and organ failure in patients undergoing endoscopic therapy for pancreatic fluid collections.
6 months
- +10 more secondary outcomes
Interventions
Patients with pancreatic fluid collections will be undergoing EUS-guided drainage and/or endoscopic necrosectomy
Eligibility Criteria
Patients with pancreatic fluid collections
You may qualify if:
- Age ≥ 18 years
- All patients undergoing endoscopic treatment of pancreatic fluid collections
You may not qualify if:
- Age \< 18 years
- Patients who did not receive endoscopic treatment of pancreatic fluid collections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orlando Health
Orlando, Florida, 21806, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ji Young Bang, MD MPH
Orlando Health, Digestive Health Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2023
First Posted
December 21, 2023
Study Start
May 1, 2021
Primary Completion (Estimated)
December 1, 2032
Study Completion (Estimated)
December 1, 2032
Last Updated
November 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share